Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Symphytum officinale extract is an investigational herbal topical treatment developed by the Universidade do Vale do Sapucaí for the management of plantar keratosis in diabetic patients. Derived from the comfrey plant, the extract contains bioactive compounds such as allantoin, which promotes cell proliferation and keratolysis, and rosmarinic acid, which provides anti-inflammatory effects. In a randomized, double-blind, controlled clinical trial (NCT03447925), the extract formulated in a vaseline base demonstrated superior efficacy in reducing the area of plantar keratosis compared to standard 10% salicylic acid. The treatment is applied topically once daily and is being evaluated as a natural alternative for skin conditions associated with the diabetic foot.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Symphytum officinale extract.